Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (231-240 of 322) with videos related to

Pageof 33
Sort By:
Nature Medicine|July 12, 2024
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Human Molecular Genetics|June 10, 2011
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complexRebecca L Zuvich, William S Bush, Jacob L McCauley, et al.
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Pageof 33

Showing results (231-240 of 322) with videos related to

Sort By:
Pageof 33
Nature Medicine|July 12, 2024
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Human Molecular Genetics|June 10, 2011
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complexRebecca L Zuvich, William S Bush, Jacob L McCauley, et al.
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Pageof 33